On March 2, the Department of Heart and Vascular Services at Chester County Hospital will host a CME event in King of Prussia for specialists in Bucks, Chester, Delaware, Lancaster and Philadelphia counties to discuss the latest procedures and treatments in heart and vascular disease.
Current Advances in Heart & Vascular Care 2019 is a CME/CNE-accredited conference designed for physicians and providers treating cardiac and vascular patients of any age.
This educational event is co-hosted in conjunction with the Pennsylvania Chapter of the American College of Cardiologists.
On the Agenda
Attendees will hear from surgeons, cardiologists, hospitalists, electrophysiologists and
emergency department specialists on topics including leadless cardiac devices -- an update on a new technology, innovations in the management of heart failure and acute stroke, the arrhythmias and the sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of diabetic medications FDA-approved for the treatment of adults with type 2 diabetes.
“We’ve planned this CME event to offer evidence-based, cost effective strategies for managing cardiovascular disease,” said Steven Weiss, MD, Chief of Cardiac Surgery at Chester County Hospital. “Our hope is to reach a comprehensive audience of providers with information that will enhance heart and vascular patient outcomes.”
A Focus on SGLT2 Inhibitors for Type 2 Diabetes
The program will feature two presentations on the SGLT2 inhibitors. The first will focus on the importance of understanding antiglycemic therapy for patients with heart failure and diabetes. The second will be a panel discussion, titled “A closer look at SGLT-2 inhibitors.” Douglas Atlas, MD, and Christopher Bruno, DO, will lead these discussions.
Current Advances in Heart & Vascular Care 2019
Saturday, March 2, 2019
Sheraton Valley Forge Hotel
480 North Gulph Road
King of Prussia, PA 19406
7am to 3pm
Additional Cardiology Resources from Penn Medicine